Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies

Name: Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies
Creator: Daniel Sturm
Published: 2021-05-04T11:06:18.777Z
Keywords: Atopic Dermatitis

Sturm, Daniel

doi:10.17632/ffx6nd5zyb.1

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies

Published: 4 May 2021| Version 1 | DOI: 10.17632/ffx6nd5zyb.1

Contributor:

Daniel Sturm

Description

Supplemental data for an article published in the Journal of the American Academy of Dermatology

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies

Description

Files

Categories

Licence